Stay up to date

News

see all news

Proteomedix presents at the annual congress of the Italian Society of Urology in Riccione and the Society of Urologists in Private Hospitals in Modena.

October 14, 2021

Proteomedix präsentiert sich an der Jahresversammlung der Schweizerischen Gesellschaft für Urologie in Interlaken.

September 23, 2021

Publications

see all publications

Development and validation of a novel multivariate risk score to guide biopsy decision for the diagnosis of clinically significant prostate cancer.

Klocker H, Golding B, Weber S, Steiner E, Tennstedt P, Keller T, Schiess R, Gillessen S, Horninger W, Steuber T. BJUI Compass. 2020;1:15–20.

Neuer diagnostischer Prozess des Prostatakarzinoms

Engeler D, Korte W, Schiess R. Pipette - Swiss Laboratory Medicine 2020;3:24-26

Events

see all events

Oct 8-9th - EAU Section of Urological Research

Virtual Meeting

Oct 16-19th - Italian Society of Urology Congress

Riccione, IT

Resources

see all resources

Application note - Implementation of Proclarix in the workflow of a clinical laboratory

Analytical validation of the Proclarix Risk Score for the diagnosis of prostate cancer

Analytical performance of automated thrombospondin-1 and cathepsin D immunoassays for prostate cancer risk assessment